CVR number 26527767
Industry 72.1900 Other research and experimental development on natural sciences and engineering

VELOXIS PHARMACEUTICALS A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmarkIFRS
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  0.0% 0.0% 3.7% 0.6% 0.9%  
Credit score (0-100)  0 0 54 98 91  
Credit rating  N/A N/A BBB AA A  
Credit limit (kUSD)  0.0 0.0 0.0 5,820.3 6,232.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kUSD) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 3,800 12,670 16,587  
Gross profit  0.0 0.0 3,800 12,670 16,587  
EBITDA  0.0 0.0 -7,075 9,217 13,453  
EBIT  0.0 0.0 -7,075 9,217 13,453  
Pre-tax profit (PTP)  0.0 0.0 -5,632.0 10,320.0 12,938.0  
Net earnings  0.0 0.0 13,046.0 11,668.0 19,505.0  
Pre-tax profit without non-rec. items  0.0 0.0 -5,632 10,320 12,938  
 
See the entire income statement

Balance sheet (kUSD) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 308 202 127  
Shareholders equity total  0.0 0.0 34,287 50,618 74,706  
Interest-bearing liabilities  0.0 0.0 13,901 25,883 0.0  
Balance sheet total (assets)  0.0 0.0 49,170 78,854 75,801  
Net Debt  0.0 0.0 11,566 19,744 -1,650  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 3,800 12,670 16,587  
Net sales growth  0.0% 0.0% 0.0% 233.4% 30.9%  
Gross profit  0.0 0.0 3,800 12,670 16,587  
Gross profit growth  0.0% 0.0% 0.0% 233.4% 30.9%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 49,170 78,854 75,801  
Balance sheet change%  0.0% 0.0% 0.0% 60.4% -3.9%  
Added value  0.0 0.0 -7,075.0 9,217.0 13,453.0  
Added value %  0.0% 0.0% -186.2% 72.7% 81.1%  
Investments  0 0 348 -113 -82  
Net sales trend  0.0 0.0 0.0 1.0 2.0  
EBIT trend  0.0 0.0 -1.0 1.0 2.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% -186.2% 72.7% 81.1%  
EBIT %  0.0% 0.0% -186.2% 72.7% 81.1%  
EBIT to gross profit (%)  0.0% 0.0% -186.2% 72.7% 81.1%  
Net Earnings %  0.0% 0.0% 343.3% 92.1% 117.6%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 343.3% 92.1% 117.6%  
Pre tax profit less extraordinaries %  0.0% 0.0% -148.2% 81.5% 78.0%  
ROA %  0.0% 0.0% -10.1% 19.7% 17.4%  
ROI %  0.0% 0.0% -10.3% 20.2% 17.8%  
ROE %  0.0% 0.0% 38.0% 27.5% 31.1%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 69.7% 64.2% 98.6%  
Relative indebtedness %  0.0% 0.0% 391.7% 222.9% 6.6%  
Relative net indebtedness %  0.0% 0.0% 330.2% 174.4% -3.3%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -163.5% 214.2% -12.3%  
Gearing %  0.0% 0.0% 40.5% 51.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 9.7% 11.4% 4.0%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 2.6 2.7 1.7  
Current Ratio  0.0 0.0 2.6 2.7 1.7  
Cash and cash equivalent  0.0 0.0 2,335.0 6,139.0 1,650.0  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 67.9% 50.0% 11.1%  
Net working capital  0.0 0.0 1,600.0 3,983.0 743.0  
Net working capital %  0.0% 0.0% 42.1% 31.4% 4.5%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0